- Steere Abramson Professor of Medicine, Department of Medicine (Rheumatology), NYU Grossman School of Medicine / NYU Langone Health, New York University
- Director, Judith & Stewart Colton Center for Autoimmunity, NYU Grossman School of Medicine / NYU Langone Health, New York University
- Associate Director for Research and Translational Medicine, Division of Rheumatology, NYU Grossman School of Medicine / NYU Langone Health, New York University
- Director, Psoriatic Arthritis Center, NYU Grossman School of Medicine / NYU Langone Health, New York University
- Director, Microbiome Center for Rheumatology and Autoimmunity (MiCRA), NYU Grossman School of Medicine / NYU Langone Health, New York University
Dr. Jose U. Scher is the Steere Abramson Professor of Medicine at NYU Grossman School of Medicine and Director of NYU Langone’s Judith & Stewart Colton Center for Autoimmunity. He also directs the NYU Psoriatic Arthritis Center and serves as Associate Director for Research and Translational Medicine in the Division of Rheumatology.
As part of the Colton Consortium for Autoimmunity, Dr. Scher is committed to a shared mission: accelerating discovery across institutions to better understand, prevent, and treat autoimmune and immune-mediated diseases. His approach is fundamentally collaborative, uniting clinicians, immunologists, microbiome scientists, computational biologists, geneticists, and bioengineers around common scientific questions — and around the shared goal of moving promising discoveries from the bench to the bedside.
Dr. Scher’s research centers on psoriatic arthritis, rheumatoid arthritis, and related autoimmune conditions, with particular interest in the immune, microbial, environmental, and molecular factors that govern disease onset, progression, and treatment response. A defining question animating his work is why some individuals develop autoimmune disease while others remain protected — and how that understanding can lead to earlier diagnosis, precision therapies, and durable remission.
He has published in leading journals including The New England Journal of Medicine, The BMJ, Science Immunology, and Immunity, and has held leadership roles with the National Psoriasis Foundation, the FDA Arthritis Advisory Committee, and the NIH ACTS study section. Originally from Buenos Aires, Dr. Scher trained at NYU Langone, where he continues to build the collaborative infrastructure that defines the Colton Consortium’s vision for transforming autoimmune disease care.